Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Viral”

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT01890200
What this trial is testing

The Effects of Adding TCM-700C on the Standard Combination Treatment for HCV Genotype 1 Patients(Phase III)

Who this might be right for
Chronic Hepatitis C
TCM Biotech International Corp.
Testing effectiveness (Phase 2)Study completedNCT01265511
What this trial is testing

Study of SCY-635, Pegasys and Copegus in Hepatitis C

Who this might be right for
Hepatitis C Infection
Scynexis, Inc. 10
Not applicableEnded earlyNCT03804814
What this trial is testing

Motivational Interviewing for HCV Elimination

Who this might be right for
Hepatitis C
Nova Scotia Health Authority 2
Large-scale testing (Phase 3)Ended earlyNCT00165633
What this trial is testing

A Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Eisai Limited 540
Early research (Phase 1)Study completedNCT00990938
What this trial is testing

Study of Combination Treatment With IMO-2125 and Ribavirin in Naïve Hepatitis C-infected, Genotype 1 Patients

Who this might be right for
Hepatitis C, Treatment Naïve, Genotype 1 Patients
Idera Pharmaceuticals, Inc. 63
Not applicableStudy completedNCT00747539
What this trial is testing

Brain Deficits in HIV/HCV Coinfected People Before and After Anti-HCV Therapy

Who this might be right for
HIVHepatitis CInfections
University of California, Los Angeles 330
Testing effectiveness (Phase 2)Study completedNCT00580801
What this trial is testing

An Exploratory Study of Telaprevir in Treatment-Naive Participants With Chronic Genotype 4 Hepatitis C Virus Infection

Who this might be right for
Hepatitis C
Tibotec BVBA 24
Post-approval studies (Phase 4)UnknownNCT00611819
What this trial is testing

Two Different Treatments 24 vs 48 Weeks Chronic Hepatitis C Genotypes 2 and/or 3 in co-Infected HIV-HCV

Who this might be right for
Chronic Hepatitis CCo-Infection HIV-HCV
University of Valencia 59
Early research (Phase 1)Study completedNCT00445419
What this trial is testing

Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

Who this might be right for
Chronic Hepatitis C
Pevion Biotech Ltd 30
Early research (Phase 1)Study completedNCT02397707
What this trial is testing

Pharmacokinetics of Voxilaprevir in Adults With Normal Hepatic Function and Moderate or Severe Hepatic Impairment

Who this might be right for
HCV Infection
Gilead Sciences 33
Testing effectiveness (Phase 2)UnknownNCT02057887
What this trial is testing

Safety,Tolerability and Pharmacokinetic Study of Recombinant Human Interferon Alfa 2B in Chronic Hepatitis C Patients (HM10660A)

Who this might be right for
Chronic Hepatitis C Virus Genotype I
Hanmi Pharmaceutical Company Limited 64
Large-scale testing (Phase 3)Study completedNCT01585584
What this trial is testing

Triple-Therapy in Patients With HCV Genotype 3 Who Previously Failed Treatment

Who this might be right for
Hepatitis C
University of Calgary 11
Not applicableStudy completedNCT03245931
What this trial is testing

Hepatitis C Education for Pregnant Women With Opiate Addiction - Phase 1

Who this might be right for
Hepatitis C
TriHealth Inc. 8
Testing effectiveness (Phase 2)Study completedNCT00018031
What this trial is testing

Peginterferon Alpha-2b And Ribavirin to Treat Hepatitis C in HIV-Infected Patients

Who this might be right for
Hepatitis CHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Large-scale testing (Phase 3)UnknownNCT00437684
What this trial is testing

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy

Who this might be right for
HIV InfectionsHepatitis C
IRCCS San Raffaele 50
Testing effectiveness (Phase 2)WithdrawnNCT01142700
What this trial is testing

BMS-824393 in Combination With Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment Naive Subjects With Chronic Hepatitis C Virus Genotype I

Who this might be right for
Chronic Hepatitis C Virus Genotype 1
Bristol-Myers Squibb
Post-approval studies (Phase 4)Study completedNCT00143000
What this trial is testing

Multicenter Study Evaluating 12 Versus 24 Weeks Therapy With Peginterferon and Ribavirin for Hepatitis C Virus (HCV) Genotype 2 or 3

Who this might be right for
Hepatitis C Virus
NORDynamIC Study Group 392
Not applicableStudy completedNCT03145844
What this trial is testing

Direct Acting Agents in Hepatitis C Patients

Who this might be right for
Hepatitis CHepatitis C RelapseHepatitis C Recurrent
Fehmi Tabak 2,700
Post-approval studies (Phase 4)Study completedNCT00383864
What this trial is testing

Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation.

Who this might be right for
Hepatitis C
Hospital Clinic of Barcelona 55
Testing effectiveness (Phase 2)Study completedNCT01309932
What this trial is testing

Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 165
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation